SCHEMBL4883341

SCHEMBL4883341

CCn1c(C(C)C)c(C=O)c2ccc(C(=O)O)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 3/20 0.43
B3GNT2 Q9NY97 1/20 0.41
METAP2 P50579 1/20 0.41
SLC22A12 Q96S37 4/20 0.40
KDM4E B2RXH2 4/20 0.40
HPGD P15428 3/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ACE2 Q9BYF1 2/20 0.39
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ACSS2 Q9NR19 1/20 0.38
PARP1 P09874 1/20 0.38
S1PR3 Q99500 1/20 0.37
PTGER4 P35408 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4885355 0.78 KDM4C (0.40) ALDH1A1SLC22A12KDM4EHPGDACE2
SCHEMBL27722947 0.71 ALDH1A1 (0.65) KMT2AALDH1A1KDM4EHPGDMEN1
SCHEMBL4880441 0.70 S1PR3 (0.63) KMT2AMEN1S1PR3RAB9A
SCHEMBL4883666 0.70 KMT2A (0.46) KMT2AALDH1A1B3GNT2KDM4EHPGD
SCHEMBL4885356 0.69 S1PR3 (0.42) KMT2AALDH1A1KDM4EMEN1S1PR3
SCHEMBL29629312 0.68 HPGD (0.65) KMT2AALDH1A1KDM4EHPGDTSHR
SCHEMBL8922345 0.68 HPGD (0.65) KMT2AALDH1A1KDM4EHPGDTSHR
SCHEMBL29629313 0.68 HPGD (0.65) KMT2AALDH1A1KDM4EHPGDTSHR
SCHEMBL7420372 0.68 KMT2A (0.56) KMT2AALDH1A1SLC22A12MEN1MAPT
SCHEMBL23809362 0.68 SLC22A12 (0.67) B3GNT2SLC22A12KDM4EACE2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524917-B2 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity ALLERGAN, INC. (US) 2013-09-03 US disclosed
US-20080171772-A1 e.g. Methyl 1-Benzyl-6-methoxy-1H-indole-2-carboxylate; glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, wound healing, platelet aggregation and thrombosis ALLERGAN, INC. 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171772-A1 e.g. Methyl 1-Benzyl-6-methoxy-1H-indole-2-carboxylate; glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, wound healing, platelet aggregation and thrombosis PTGIR, S1PR1, TBXA2R KMT2A 2192/4885ALDH1A1 1333/4885B3GNT2 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.